Clinical Trials List
2024-09-15 - 2029-12-31
Phase II
Recruiting5
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- MING YAO 無
- 倪紹之 無
- Huai-Hsuan Huang 無
- CHENG-HONG TSAI 無
- 李思慧 無
- KUAN-YIN KO 無
- 莊佩儒 無
- CHING-CHU LU 無
- 魏兆宏 無
- 林耘曲 無
- 陳睿哲 無
- 劉家豪 無
- 邱柏儒 無
- 洪聖祐 無
- Tai-Chung Huang 無
- 劉高郎 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ping Chen 無
- Sin-Syue Li 無
- 傅蓓安 無
- Ya-Ting Hsu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王幸婷 無
- Chi-Ching Chen 無
- Ching Yun Hsieh 無
- Che-Hung Lin 無
- 陳珈妤 無
- Wei-Ching Lin 無
- Ming-Yu Lien 無
- 鄭富銘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
240 participants
